[CLDX] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -29.81%
YoY- -144.78%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 333 3,786 887 1,764 3,456 1,874 1,790 -24.42%
PBT -20,148 -22,839 -10,447 -9,402 -22,923 -32,307 -32,684 -7.73%
Tax -874 -939 -4,448 -8,746 -19,082 -5,090 836 -
NP -20,148 -21,900 -10,447 -9,402 -3,841 -32,307 -32,684 -7.73%
Tax Rate - - - - - - - -
Total Cost 20,481 25,686 11,334 11,166 7,297 34,181 34,474 -8.30%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -6,050.45 -578.45 -1,177.79 -532.99 -111.14 -1,723.96 -1,825.92 22.07%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.43 -0.55 -0.64 -0.81 -0.42 -4.49 -4.97 -33.47%
EPS Diluted -0.43 -0.55 -0.64 -0.81 -0.41 -4.49 -4.97 -33.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.